Emami Limited (EMAMILTD.BO)
INR 623.75
(-3.38%)
INR 623.75
(-3.38%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.21 Billion INR | 3.12% |
| 2022 | 7.97 Billion INR | -18.93% |
| 2021 | 9.83 Billion INR | 29.72% |
| 2020 | 7.57 Billion INR | -11.42% |
| 2019 | 8.55 Billion INR | 14.61% |
| 2018 | 7.46 Billion INR | -5.09% |
| 2017 | 7.86 Billion INR | -7.14% |
| 2016 | 8.47 Billion INR | -21.32% |
| 2015 | 10.76 Billion INR | 144.04% |
| 2014 | 4.41 Billion INR | 19.17% |
| 2013 | 3.7 Billion INR | -15.61% |
| 2012 | 4.38 Billion INR | -4.69% |
| 2011 | 4.6 Billion INR | 12.76% |
| 2010 | 4.08 Billion INR | -4.67% |
| 2009 | 4.28 Billion INR | -32.1% |
| 2008 | 6.3 Billion INR | 141.56% |
| 2007 | 2.61 Billion INR | 153.36% |
| 2006 | 1.03 Billion INR | 38.88% |
| 2005 | 741.82 Million INR | 35.68% |
| 2004 | 546.75 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -24.57 Billion INR | -399.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 8.21 Billion INR | 3.12% |
| 2023 Q4 | 8.21 Billion INR | 0.0% |
| 2023 Q2 | 9.02 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 8.3 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 7.97 Billion INR | 0.0% |
| 2022 FY | 7.97 Billion INR | -18.93% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 7.76 Billion INR | 0.0% |
| 2021 FY | 9.83 Billion INR | 29.72% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 9.83 Billion INR | 0.0% |
| 2020 FY | 7.57 Billion INR | -11.42% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 8.77 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 7.57 Billion INR | 0.0% |
| 2019 Q4 | 8.55 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 8.55 Billion INR | 14.61% |
| 2019 Q2 | 8.9 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 7.46 Billion INR | -5.09% |
| 2018 Q4 | 7.46 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 8.58 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 7.86 Billion INR | -7.14% |
| 2017 Q4 | 7.86 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 11.15 Billion INR | 0.0% |
| 2016 Q4 | 8.47 Billion INR | 0.0% |
| 2016 FY | 8.47 Billion INR | -21.32% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 13.95 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 10.76 Billion INR | 144.04% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q2 | 12.96 Billion INR | 0.0% |
| 2015 Q4 | 10.76 Billion INR | 0.0% |
| 2014 Q4 | 4.41 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 4.41 Billion INR | 19.17% |
| 2014 Q2 | 4.33 Billion INR | 0.0% |
| 2013 Q4 | 3.7 Billion INR | 0.0% |
| 2013 FY | 3.7 Billion INR | -15.61% |
| 2013 Q2 | 3.89 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2012 FY | 4.38 Billion INR | -4.69% |
| 2012 Q4 | 4.38 Billion INR | 0.0% |
| 2011 FY | 4.6 Billion INR | 12.76% |
| 2011 Q4 | 4.6 Billion INR | 0.0% |
| 2010 FY | 4.08 Billion INR | -4.67% |
| 2009 FY | 4.28 Billion INR | -32.1% |
| 2008 FY | 6.3 Billion INR | 141.56% |
| 2007 FY | 2.61 Billion INR | 153.36% |
| 2006 FY | 1.03 Billion INR | 38.88% |
| 2005 FY | 741.82 Million INR | 35.68% |
| 2004 FY | 546.75 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ador Multiproducts Limited | 28.52 Million INR | -28713.446% |
| Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -647.398% |
| Bajaj Consumer Care Limited | 1.53 Billion INR | -437.245% |
| Colgate-Palmolive (India) Limited | 13.22 Billion INR | 37.83% |
| Cupid Limited | 186.52 Million INR | -4306.839% |
| Dabur India Limited | 48.19 Billion INR | 82.945% |
| Gillette India Limited | 8.59 Billion INR | 4.362% |
| Godrej Consumer Products Limited | 58.97 Billion INR | 86.062% |
| Hindustan Unilever Limited | 270.76 Billion INR | 96.964% |
| Hipolin Limited | 48.57 Million INR | -16822.776% |
| Honasa Consumer Limited | 5.36 Billion INR | -53.135% |
| JHS Svendgaard Laboratories Limited | 271.7 Million INR | -2925.292% |
| Jyothy Labs Limited | 5.9 Billion INR | -39.151% |
| Kaya Limited | 5.22 Billion INR | -57.397% |
| Marico Limited | 32.52 Billion INR | 74.724% |
| N.K Industries Limited | 22.4 Billion INR | 63.309% |
| PAOS INDUSTRIES LIMITED | 163.96 Million INR | -4913.082% |
| Paramount Cosmetics (India) Limited | 205.72 Million INR | -3895.577% |
| Pee Cee Cosma Sope Limited | 80.17 Million INR | -10151.936% |
| Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 24.15% |